U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
On the vaccine front, an official with the FDA is suggesting a fourth dose of the COVID-19 vaccine might be needed closer to fall.
Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness.
In the midst of the surge of COVID cases the FDA is now allowing Pfizer booster shots for children as young as 12 years old.
The Food and Drug Administration on Monday allowed extra Pfizer shots for children as young as 12. Boosters already are recommended for everyone 16 and older, and the FDA says they’re also warranted for 12- to 15-year-olds.
Final data on Pfizer’s experimental treatment for COVID-19 has now been shared with the FDA. It’s part of the company’s application to authorize the pill for emergency use.
The Food and Drug Administration has opened up COVID-19 booster shots to all adults, letting them choose another dose of either the Pfizer or Moderna vaccine. But there’s one more step: The Centers for Disease Control and Prevention must agree that even healthy young adults should get either a Pfizer or Moderna booster.
Moderna says the Food and Drug Administration needs more time to review its COVID-19 vaccine in teenagers. Moderna says the FDA wants to review the risk of heart inflammation in its vaccine in children and teens ages 12-17.
The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.
Health officials are closing in on a decision about Pfizer’s COVID-19 vaccine for kids ages 5-11, but a new survey shows significant hesitancy among parents to get young children vaccinated.
